| Treatment of established tumors with a novel vaccine that enhances major histocompatibility class II presentation of tumor antigen KY Lin, FG Guarnieri, KF Staveley-O'Carroll, HI Levitsky, JT August, ... Cancer research 56 (1), 21-26, 1996 | 1208 | 1996 |
| Targeting human papillomavirus type 16 E7 to the endosomal/lysosomal compartment enhances the antitumor immunity of DNA vaccines against murine human papillomavirus type 16 E7 … H Ji, TL Wang, CH Chen, SI Pai, CF Hung, KY Lin, RJ Kurman, ... Human gene therapy 10 (17), 2004 | 230 | 2004 |
| Cervical cancer immunotherapy: facts and hopes L Ferrall, KY Lin, RBS Roden, CF Hung, TC Wu Clinical Cancer Research 27 (18), 4953-4973, 2021 | 171 | 2021 |
| Antigen‐specific immunotherapy for murine lung metastatic tumors expressing human papillomavirus type 16 E7 oncoprotein H Ji, EY Chang, KY Lin, RJ Kurman, DM Pardoll, TC Wu International journal of cancer 78 (1), 41-45, 1998 | 157 | 1998 |
| Therapeutic hpv DNA vaccines K Lin, E Roosinovich, B Ma, CF Hung, TC Wu Immunologic research 47, 86-112, 2010 | 155 | 2010 |
| Perspectives for preventive and therapeutic HPV vaccines K Lin, K Doolan, CF Hung, TC Wu Journal of the Formosan Medical Association 109 (1), 4-24, 2010 | 152 | 2010 |
| Cell surface-binding motifs of L2 that facilitate papillomavirus infection R Yang, PM Day, WH Yutzy IV, KY Lin, CF Hung, RBS Roden Journal of virology 77 (6), 3531-3541, 2003 | 152 | 2003 |
| PARP inhibitors for cancer therapy KY Lin, WL Kraus Cell 169 (2), 183, 2017 | 106 | 2017 |
| Ectopic expression of vascular cell adhesion molecule-1 as a new mechanism for tumor immune evasion KY Lin, D Lu, CF Hung, S Peng, L Huang, C Jie, F Murillo, J Rowley, ... Cancer research 67 (4), 1832-1841, 2007 | 106 | 2007 |
| Long noncoding RNAs in cancer: from discovery to therapeutic targets R Choudhari, MJ Sedano, AL Harrison, R Subramani, KY Lin, EI Ramos, ... Advances in clinical chemistry 95, 105-147, 2020 | 103 | 2020 |
| Activation of Akt as a mechanism for tumor immune evasion KH Noh, TH Kang, JH Kim, SI Pai, KY Lin, CF Hung, TC Wu, TW Kim Molecular therapy 17 (3), 439-447, 2009 | 99 | 2009 |
| Cervical cancer JS Lea, KY Lin Obstetrics and Gynecology Clinics 39 (2), 233-253, 2012 | 84 | 2012 |
| CD8+ T cells, NK cells and IFN-γ are important for control of tumor with downregulated MHC class I expression by DNA vaccination WF Cheng, CF Hung, KY Lin, M Ling, J Juang, L He, CT Lin, TC Wu Gene therapy 10 (16), 1311-1320, 2003 | 78 | 2003 |
| Boosting with recombinant vaccinia increases HPV-16 E7-Specific T cell precursor frequencies and antitumor effects of HPV-16 E7-expressing Sindbis virus replicon particles CT Lin, CF Hung, J Juang, L He, KY Lin, T WooKim, TC Wu Molecular Therapy 8 (4), 559-566, 2003 | 71 | 2003 |
| Risk of occult uterine sarcoma in women undergoing hysterectomy for benign indications KA Kho, K Lin, M Hechanova, DL Richardson Obstetrics & Gynecology 127 (3), 468-473, 2016 | 64 | 2016 |
| Listeria delivers tetanus toxoid protein to pancreatic tumors and induces cancer cell death in mice BC Selvanesan, D Chandra, W Quispe-Tintaya, A Jahangir, A Patel, ... Science translational medicine 14 (637), eabc1600, 2022 | 53 | 2022 |
| Coinfection of HPV‐11 and HPV‐16 in a case of laryngeal squamous papillomas with severe dysplasia KY Lin, WH Westra, HK Kashima, P Mounts, TC Wu The Laryngoscope 107 (7), 942-947, 1997 | 45 | 1997 |
| Targeting HPV-16 E7 to the endosomal/lysosomal compartment enhances the antitumor immunity of DNA vaccines against murine HPV-16 E7-expressing tumors H Ji, TL Wang, CH Chen, CF Hung, S Pai, KY Lin, RJ Kurman, DM Pardoll, ... Hum Gene Ther 10 (17), 2727-40, 1999 | 44 | 1999 |
| Malignant ovarian germ cell tumor—Role of surgical staging and gonadal dysgenesis KY Lin, S Bryant, DS Miller, SM Kehoe, DL Richardson, JS Lea Gynecologic oncology 134 (1), 84-89, 2014 | 42 | 2014 |
| Ovarian involvement in endometrioid adenocarcinoma of uterus KY Lin, DS Miller, AA Bailey, SJ Andrews, SM Kehoe, DL Richardson, ... Gynecologic oncology 138 (3), 532-535, 2015 | 41 | 2015 |
